Ventria will present ExpressTec at the Kansas Pavilion in the Exhibit Hall and will participate in BIO’s One-on-One Partnering Sessions.
Fort Collins, CO, USA, June 23, 2011 / B3C newswire / – Ventria announced that Company representatives will attend the Annual BIO Convention in Washington DC, June 27th-30th, 2011. This is the largest international event for the biotechnology industry with over 15,000 attendees from 60 countries.
Ventria will be exhibiting as part of the Kansas Pavilion at booth number 4637 and will be participating in BIO’s One-on-One partnering sessions.
“Ventria is excited to be joining the biotech industry in Washington, DC. The innovative spirit of the biotech industry thrives when we collaborate and create win-win relationships that deliver better healthcare outcomes for patients around the world,” said Scott Deeter, President and CEO, Ventria Bioscience.
About Ventria Bioscience
Ventria Bioscience is the first company to commercialize recombinant proteins derived from a plant-based manufacturing system. Ventria’s patented ExpressTec system is a safe, affordable and sustainable manufacturing technology that achieves recombinant protein yield that is ten times higher than alternative systems. This advantage means Ventria’s products are accessible to a global customer base. Ventria’s product portfolio includes nine commercial products and several new products in development. Ventria’s products target three markets: human health, cell culture and biomanufacturing, and zoonotic disease.
Contact
Ventria Bioscience
320 E Vine Drive
Fort Collins, CO 80524